...
首页> 外文期刊>Vaccine >Mucosal immune responses to meningococcal C polysaccharide-protein conjugate in mice
【24h】

Mucosal immune responses to meningococcal C polysaccharide-protein conjugate in mice

机译:对小鼠脑膜炎球菌C多糖-蛋白结合物的粘膜免疫反应

获取原文
获取原文并翻译 | 示例
           

摘要

Mucosal delivery of vaccines represents an attractive approach because this is a region of first contact point for inhaled antigens. We have obtained a meningococcal group C polysaccharide-tetanus toxoid conjugate (MGCP-TT) and evaluated it for intranasal route in mice. The conjugate was obtained by a developed method in our laboratory. The specific IgA in saliva and specific IgA and IgG in serum were measured by ELISA methods and bactericidal antibodies in sera against a meningococcal group C strain were measured. The conjugated elicited a significant increase in anti-MGCP salivary IgA and serum IgG and bactericidal antibodies concentrations, while specific serum IgA was not observed. These results indicated that after conjugation, there was a change in the responses for MGCP from thymus-independent to thymus-dependent and that it was effective by intranasal route.
机译:疫苗的粘膜递送代表了一种有吸引力的方法,因为这是吸入抗原的第一个接触点区域。我们已经获得了脑膜炎球菌C组多糖-破伤风类毒素缀合物(MGCP-TT),并对其在小鼠中的鼻内途径进行了评估。该缀合物通过我们实验室中的发达方法获得。通过ELISA方法测量唾液中的特异性IgA以及血清中的特异性IgA和IgG,并且测量针对脑膜炎球菌C组菌株的血清中的杀菌抗体。结合物引起抗MGCP唾液IgA和血清IgG和杀菌抗体浓度的显着增加,而未观察到特异性血清IgA。这些结果表明,结合后,MGCP的应答从不依赖胸腺变为依赖胸腺,并且通过鼻内途径有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号